In its recent epidemiological bulletin (no. 15) the German Robert Koch Institute reports about exceedingly high numbers of hantavirus infections in Germany. In total, 1,713 cases had been registered in 2017 – in the previous year, there were only 298. Indeed, the number of infections fluctuates considerably from year to year. Also 2007, 2010 and 2012 were […]
Previous year, EUROIMMUN launched the Anti-Zika Virus ELISA IgA. It had turned out that specific anti-Zika virus IgA antibodies against the non-structural protein 1 (NS1) could serve as alternative indicators of acute infection phase if specific IgM antibodies were not detectable. Particularly when patients, who already have had a first contact with a flavivirus (infection
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar on February 15th, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS addressed the current epidemiologic status of measles and mumps, challenges and solutions in serological testing,
When antibodies of class IgE against the peanut proteins Ara h2 and Ara h6 are detected in a patient sample, this finding points with high probability to a clinical peanut allergy. After eating a peanut, the binding between IgE antibodies and their target proteins leads to the activation of mast cells. The activated immune cells
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS address the current epidemiologic status of measles and mumps, challenges and solutions in serological testing, perspectives in vaccine
